1. 2015
  2. Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

    Lindenberg, L., Spengler, L., Bang, H., Dorner, T., Maslyanskiy, A. L., Lapin, S. V., Ilivanova, E. I., Martinez-Gamboa, L., Bastian, H., Wittenborn, E., Egerer, K., Burmester, G. R. & Feist, E., 13 Aug 2015, In: Arthritis Research and Therapy. 17, 1, 206.

    Research output: Contribution to journalArticlepeer-review

  3. Inflammatory mediators role in atherosclerotic lesion development in the large arteries in patients with systemic sclerodermia

    Maslyansky, A. L., Kolesova, E. P., Kozlenok, A. V., Vasilieva, E. Y., Penin, I. N., Rotar, O. P., Lazareva, N. M., Lapin, S. V., Sysoev, K. A., Solntsev, V. N., Bazhenov, A. N. & Konradi, A. O., 2015, In: Cardiovascular Therapy and Prevention (Russian Federation). 14, 3, p. 4-11 8 p.

    Research output: Contribution to journalArticlepeer-review

  4. 2014
  5. Synthesis of Some CC Chemokines and Their Receptors in the Synovium in Rheumatoid Arthritis

    Zhebrun, D. A., Totolyan, A. A., Maslyanskii, A. L., Titov, A. G., Patrukhin, A. P., Kostareva, A. A. & Gol’tseva, I. S., 1 Dec 2014, In: Bulletin of Experimental Biology and Medicine. 158, 2, p. 192-196 5 p.

    Research output: Contribution to journalArticlepeer-review

  6. Effects of rituximab therapy on elastic properties of vascular wall in patients with progressive systemic sclerosis

    Maslyanskiy, A. L., Lapin, S. V., Kolesova, E. P., Penin, I. N., Cheshuina, M. D., Feist, E. & Konradi, A. O., 1 Nov 2014, In: Clinical and Experimental Rheumatology. 32, 6, p. S-228

    Research output: Contribution to journalLetterpeer-review

  7. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis

    Maslyanskiy, A., Lazareva, N., Olinek, P., Schierack, P., Hentschel, C., Cuccato, J., Bogdanos, D. P., Lapin, S. V. & Roggenbuck, D., 2014, In: Journal of Immunology Research. 2014, 516593.

    Research output: Contribution to journalArticlepeer-review

  8. 2013
  9. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., Doyle, M. K., Aelion, J., Akovbyan, G., Andersone, D., Bakulev, A., Basijokiene, V., Beaulieu, A., Birbara, C., Boh, E., Bourcier, M. & 100 others, Braun, J., Brzezicki, J., Buchanan, R., Budd, J., Bukauskiene, L., Burnette, M., Crespillo, J. C., Carey, W., Chattapadhyay, C., Chudzik, D., Cooper, R., Drescher, E., Dudek, A., Dutz, J., El-Kadi, H., Erlacher, L., Fretzin, S. A., Garcia Meijide, J. A., George, E., Gilchrist, N., Gladstein, G., Gow, P., Graninger, W., Griffin, R. M., Guenther, L., Gulliver, W., Hall, S., Halter, D. G., Hobbs, K., Ilivanova, E., Jarvinen, P., Jeka, S., Jones, P., Khraishi, M., Kokhan, M., Kovacs, A., Kovacs, L., Kubanov, A., Kunynetz, R., Langley, R., Lee, S., Leonardi, C. L., Lessard, C., Lietuvininkiene, V., Lizzul, P., Martin, A., Maslyanskiy, A., Matheson, R. T., Mikazane, H., Murphy, F. T., Nash, P., Nasonov, E., Sarabia, F. N., Orlov-Morozov, A., Paimela, L., Palmer, W., Papp, K., Pileckyte, M., Poor, G., Poulin, Y., Silva, R. Q., Rapoport, R., Rebrov, A., Rell-Bakalarska, M., Rich, P., Rischmueller, M., Rojkovich, B., Rosen, C., Rosoph, L., Scheinecker, C., Schopf, R., Sebastian, M., Seigel, S., Shaikh, S., Sheeran, T., Shergy, W. J., Shirinsky, V., Siegel, E. L., Sofen, H., Sterry, W., Supronik, J., Szabo, Z., Szanyo, F., Tahir, H., Tan, J., Taylor, W., Temnikov, V., Thaci, D., Toth, D., Újfalussy, I., Valleala, H., Vender, R., Wasel, N., Willans, M., Wollenhaupt, J., Zamani, O., Zanetakis, E., Zonova, E., Zoschke, D. & Zubrzycka-Sienkiewicz, A., 2013, In: The Lancet. 382, 9894, p. 780-789 10 p.

    Research output: Contribution to journalArticlepeer-review

  10. The value of quantitative analysis of procalcitonine in diagnostics of septic complications in patients with autoimmune rheumatic diseases

    Lapin, S. V., Maslyanskiy, A. L., Lazareva, N. M., Vasilyeva, Y. Y. & Totolyan, A. A., 2013, In: Klinichescheskaya Laboratornaya Diagnostika. 1, p. 28-33 6 p.

    Research output: Contribution to journalArticlepeer-review

  11. 2011
  12. Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population

    Zhebrun, D., Kudryashova, Y., Babenko, A., Maslyansky, A., Kunitskaya, N., Popcova, D., Klushina, A., Grineva, E., Kostareva, A. & Shlyakhto, E., Apr 2011, In: Aging. 3, 4, p. 368-373 6 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 Next

ID: 85577564